Read transcripts of debates in both Houses
Produced by Commons Library, Lords Library and Parliamentary Office Science and Technology
Search for Members by name, postcode, constituency and party
Learn about their experience, knowledge and interests
Celebrating people who have made Parliament a positive, inclusive working environment
Four staff networks for people to discuss and consider issues.
Contact your MP or a Member of the House of Lords about an issue that matters to you
Sign up for the Your Parliament newsletter to find out how you can get involved
Take a tour of Parliament and enjoy a delicious afternoon tea by the River Thames
See some of the sights you’ll encounter on a tour of Parliament
Book a school visit, classroom workshop or teacher-training session
Access videos, worksheets, lesson plans and games
Follow this EDM by:
That this House welcomes the double-blind study conducted at the outpatient clinic at Jundiai Medical School in São Paulo, Brazil, which consisted of patients with moderate to severe depression; notes that patients were randomly assigned to a double-blind treatment with individualised homeopathic Q-potencies or fluoxetine (Prozac); further notes that the non-inferiority analysis indicated that the homeopathic Q-potencies were not inferior as compared to fluoxetine in treatment of this sample; observes that the study is the first randomised controlled double-blind trial with a reasonable number of subjects to draw conclusions about the homeopathic treatment of depression; acknowledges that homeopathy is recognised as a medical specialty in Brazil; and calls on the Government to carry out further research into this area.
Total number of signatures: 14
Showing 14 out of 14
leave out from `House' to end and insert `notes the study published in August 2009 in the journal e-Cam by UC Adler et al, conducted in São Paulo on 91 patients with depression, which claimed that individualised homeopathic treatments were not inferior to fluoxetine, a selective serotonin reuptake inhibitor; further notes that only 55 patients completed the study and that the finding of non-inferiority, while statistically significant, was marginal; further notes that fluoxetine is considered by many to be no more or barely more effective than a placebo in such patients and that this study therefore merely provides further evidence that homeopathy treatment is no more effective than placebo treatment; and supports the findings of the Fourth Report from the Science and Technology Select Committee of Session 2009-10, Evidence Check 2: Homeopathy, HC45, namely that there are ethical problems in prescribing patients placebos without full candour, that the evidence base is clear that homeopathy is not effective beyond placebo and so scarce NHS funds should not be spent commissioning it at a time when, due to cost, the health service is not even able to provide its patients with treatments that have been clearly shown to be effective, and that putting patients through pointless further clinical trials, and the spending of scarce public sector funds on research into homeopathy cannot be justified.'.
Total number of signatures: 10
Showing 10 out of 10